← Open Payments lookup

MUHIBA BEGUM: Open Payments

NPI 1821716994 · EMERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,821 in 59 payments from 11 companies in 2025. Trend: 2023 $64 · 2024 $503 · 2025 $1,821

Food & beverage: $1,821
CompanyPaymentsAmount
ABBVIE INC.14$350
Vanda Pharmaceuticals Inc.6$272
Neurocrine BioSciences, Inc.9$236
Otsuka America Pharmaceutical, Inc.6$204
Alkermes, Inc.6$193
Almatica Pharma LLC11$153
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$120
Axsome Therapeutics, Inc.1$117
Teva Pharmaceuticals USA, Inc.1$109
E.R. Squibb & Sons, L.L.C.3$50

Products named: VRAYLAR, FANAPT, INGREZZA, REXULTI, LOREEV XR, LYBALVI, CAPLYTA, Auvelity.

Industry payments across NJ — which companies pay providers there.